Your browser doesn't support javascript.
loading
Hepatic Innervations and Nonalcoholic Fatty Liver Disease.
Adori, Monika; Bhat, Sadam; Gramignoli, Roberto; Valladolid-Acebes, Ismael; Bengtsson, Tore; Uhlèn, Mathias; Adori, Csaba.
Afiliação
  • Adori M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Bhat S; Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Gramignoli R; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Valladolid-Acebes I; Department of Molecular Medicine and Surgery, The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Stockholm, Sweden.
  • Bengtsson T; Department of Molecular Biosciences, The Wenner-Gren Institute (MBW), Stockholm University, Stockholm, Sweden.
  • Uhlèn M; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Adori C; Science for Life Laboratory, Royal Institute of Technology, Stockholm, Sweden.
Semin Liver Dis ; 43(2): 149-162, 2023 05.
Article em En | MEDLINE | ID: mdl-37156523
ABSTRACT
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder. Increased sympathetic (noradrenergic) nerve tone has a complex role in the etiopathomechanism of NAFLD, affecting the development/progression of steatosis, inflammation, fibrosis, and liver hemodynamical alterations. Also, lipid sensing by vagal afferent fibers is an important player in the development of hepatic steatosis. Moreover, disorganization and progressive degeneration of liver sympathetic nerves were recently described in human and experimental NAFLD. These structural alterations likely come along with impaired liver sympathetic nerve functionality and lack of adequate hepatic noradrenergic signaling. Here, we first overview the anatomy and physiology of liver nerves. Then, we discuss the nerve impairments in NAFLD and their pathophysiological consequences in hepatic metabolism, inflammation, fibrosis, and hemodynamics. We conclude that further studies considering the spatial-temporal dynamics of structural and functional changes in the hepatic nervous system may lead to more targeted pharmacotherapeutic advances in NAFLD.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article